Why Astera Labs Stock Is Plummeting Today

Core Viewpoint - Astera Labs' stock is experiencing a significant sell-off despite reporting strong Q4 results, primarily due to management changes and concerns over future margins [1][4]. Financial Performance - Astera Labs reported non-GAAP earnings per share of $0.58 on revenue of $270.6 million, surpassing Wall Street estimates of $0.51 per share and $249.55 million in sales [3]. - Revenue increased nearly 92% year over year, while adjusted earnings per share rose approximately 57% compared to the previous year [4]. Guidance and Outlook - For the current quarter, Astera Labs is guiding for sales between $286 million and $297 million, with a projected gross margin of around 74% [5]. - Adjusted earnings per share are expected to be between $0.53 and $0.54, which is ahead of expectations on most key fronts [5]. Management Changes - The resignation of CFO Mike Tate, who will transition to a strategic advisor role, has contributed to the stock's decline. Desmond Lynch will take over as CFO on March 2 [6]. - Management changes often lead to stock volatility, and the current bearish reaction may be an overreaction [6].